Proactive - Interviews for investors

Lightning Minerals Ltd (ASX:L1M) managing director Alex Biggs joins Proactive’s Tylah Tully to discuss soil sampling and ground reconnaissance initiated at the Esperança Lithium Project in Minas Gerais' Lithium Valley, Brazil.

This follows the signing of an option agreement to acquire the project in August 2024.

The on-ground exploration team, currently working at the Canabrava and Caraíbas lithium projects, will apply a similar approach at Esperança, focusing on soil sampling, ground reconnaissance and geophysical interpretation.

The Esperança exploration will cover ~500 soil samples to test the area’s potential for lithium deposits, particularly around Salinas Formation rocks close to granites.

Early results from the Canabrava project have already identified elevated lithium levels in soil assays up to 113ppm and additional results are expected soon from Caraíbas.

Lightning Minerals is expediting its exploration activities by securing local teams to conduct the soil campaign quickly and cost-effectively.

Biggs highlighted the importance of these efforts in consolidating their land holdings in the under-explored Lithium Valley, aiming for prioritised drill targeting in the coming months.

Lightning is also undertaking targeted infill soil sampling at its Dundas Lithium Project in Western Australia to further define lithium drill targets as it tests previously identified lithium in soil anomalism of up to 147ppm

#ProactiveInvestors #LightningMinerals #ASX #LithiumExploration #EsperançaProject #LithiumValley #BrazilLithium #CanabravaProject #CaraíbasProject #SoilSampling #Geophysics #MiningExploration #LithiumDeposits #BatteryMetals #MineralExploration #SustainableEnergy #RenewableEnergy #CleanEnergy #MiningNews #Geology #Pegmatites #GreenEnergy #MineralsExploration #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) CEO James Graham joins Proactive’s Tylah Tully to discuss progress in a Phase II clinical trial for the topical gel RECCE® 327 (R327G).

Recce has formally reached the halfway point, with 15 patients successfully dosed. The trial is assessing the efficacy of R327G against Acute Bacterial Skin and Skin Structure Infections (ABSSSI), including diabetic foot infections and other wound infections, which are areas of significant unmet medical need.

Early data shows that R327G is well tolerated, with promising antibacterial effects observed across a range of infections. The trial aims to enrol 30 participants by the end of 2024.

The clinical study locations have expanded, now including Barwon Health, Australian Clinical Research Network NSW and ACRN Melbourne, increasing access to this novel treatment.

The global ABSSSI market was valued at US$1.34 billion in 2023 and is projected to grow to US$2.31 billion over the next decade. An interim clinical review is scheduled for mid-October 2024 with further results expected shortly thereafter.

Graham expressed optimism about the trial’s progress and the potential impact of R327G on the growing global healthcare need for effective treatments against drug-resistant bacterial infections.

#ProactiveInvestors #ReccePharmaceuticals #ASX #R327G #Phase2Trial #ABSSSI #WoundInfections #DiabeticFootInfections #ClinicalTrial #AntibacterialGel #BroadSpectrumAntimicrobial #SkinInfections #DrugResistantBacteria #HealthcareInnovation #BarwonHealth #ClinicalResearch #Australia #InfectiousDiseases #BacterialInfections #MedicalResearch #Biotechnology #TGA

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Iondrive Ltd (ASX:ION) CEO Dr Ebbe Dommisse joins Proactive’s Tylah Tully to discuss a non-binding Memorandum of Understanding (MoU) signed with TNO, a Netherlands-based research & technology organisation.

Through the MoU the parties hope to accelerate the commercialisation of Iondrive’s sustainable battery recycling technology and strengthen the battery materials supply chain in the Netherlands and the EU by enhancing production capabilities and validating the technology for large-scale deployment. A key objective of the MoU is to establish industry partnerships and commercialisation opportunities.

This agreement follows Iondrive’s recent partnership with PEM Motion and RWTH Aachen University in Germany, forming a pan-European strategy to promote regionalised battery recycling.

Iondrive’s pre-feasibility study is set for completion in October 2024 with plans to build a pilot plant by 2025. TNO’s expertise in sustainable innovation will support Iondrive’s goal of meeting the EU’s growing demand for recycled battery materials, particularly in line with new regulations for high recovery levels of critical materials like cobalt, lithium, and nickel by 2025.

#ProactiveInvestors #Iondrive #ASX #TNO #BatteryRecycling #Sustainability #BatteryTechnology #EnergyTransition #RecyclingInnovation #CircularEconomy #EURegulations #Lithium #Cobalt #Nickel #BatterySupplyChain #EuropeanGreenDeal #RWTHAachen #PEMMotion #BlackMass #BatteryMaterials #SustainableSolutions #Netherlands #Commercialisation

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Botala Energy Ltd (ASX:BTE) director and chair Wolf Martinick joins Proactive’s Tylah Tully to discuss the company’s progress in Botswana with the company receiving environmental approval from the Department of Environmental Protection for the development of its Serowe Energy Hub.

The project will include liquefied natural gas (LNG) storage and distribution facilities, a 24-megawatt (MW) solar/gas hybrid power plant, a 4MW solar tender to supply the local grid, service and storage facilities, and a small market gardening area.

This approval covers all aspects of Botala's proposed gasfield and energy development plans, including commercial gas production, LNG facilities and pipelines connecting the Serowe gasfield to Leupane.

The Serowe Energy Hub is part of a larger effort to supply LNG and electricity locally and to neighbouring countries.

Botala is also preparing to start development on a 4MW solar project, with local stakeholders including the Serowe community's Ngwato Development Trust. In addition, the company is focused on its Serowe coal bed methane gas project and the development of the larger Leupane Energy Hub. #ProactiveInvestors #BotalaEnergy #ASX #SeroweEnergyHub #LNG #SolarEnergy #BotswanaEnergy #GasProduction #EnergyHub #RenewableEnergy #HybridPowerPlant #EnvironmentalApproval #CoalBedMethane #EnergyDevelopment #SustainableEnergy #SouthAfricaEnergy #CleanEnergy #EnergyTransition #PowerPlant #SolarPower #GasPipeline #EnergyInfrastructure

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Arizona Gold and Silver CEO Mike Stark joined Steve Darling from Proactive to share news that, due to strong investor demand, the company's non-brokered private placement has been increased to total proceeds of $4.6 million. The company said that raise also included Sprott and Rick Rule to its share registry. These funds will support the company’s upcoming exploration activities at its Flagship Philadelphia Property.

Stark shared with Proactive that site preparation is almost complete for diamond core drilling at the Red Hills bulk tonnage target within the Philadelphia property. This target represents the down-dip extension of known mineralization and the western edge of a CSAMT anomaly beneath a hydrothermally altered dome known as Red Hill. The new drilling, which will occur on BLM-administered unpatented claims, will test mineralization further both along strike and down dip to the east. Drilling permits were recently received, and each drill hole is expected to take between 10 to 20 days to complete.

#proactiveinvestors #arizonagoldandsilverinc #tsxv #azs #otcqb #azasf

#GoldExploration #MiningNews #PhiladelphiaProject #RedHillsDrilling #RickRule #SprottGroup #GoldInvesting #JuniorMining #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

StickIt Technologies Head of Research Shawn Ripley joined Steve Darling from Proactive to share exciting developments with Proactive regarding the company's innovative approach to cannabinoid consumption. The Israeli tech and cannabinoid company has introduced the StickIt SipIt straw, a patented product that allows users to consume CBD/THC by sipping their favorite beverages. Ripley emphasized that the SipIt straw provides a new consumption method that delivers cannabinoids efficiently, without the bitterness, chemicals, or smoke often associated with traditional methods. Users can feel the effects of cannabinoids within minutes.

StickIt Technologies operates through a joint venture and licensing model, establishing production facilities worldwide to customize products with various cannabinoid contents for both recreational and medical use. Additionally, the company announced a global reorganization, including moving its raw material production to Calgary, Canada, which is expected to significantly reduce operating expenses. Ripley also discussed their plans to expand the SipIT straw into Canadian and U.S. markets, emphasizing partnerships with distributors across various regions.

#proactiveinvestors #stickittechnologiesinc #cse #stkt #cannabinoid #sipitstraw

#SipITStraw #Cannabinoids #THC #CBD #StickITTechnologies #CannabisProducts #CannabisMarket #CannabisConsumption #CannabisTech #CannabisExpansion #CannabisBusiness #CannabisInfusion #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Delivra Health Brands CEO Gord Davey joined Steve Darling from Proactive to share news shared updates with Proactive regarding the company’s financial and operating results for the fiscal year ending June 30, 2024. Delivra Health, known for its Dream Water® and LivRelief™ brands, which address health concerns like sleeplessness, chronic pain, and anxiety, continues to show financial growth and stability.

For the second consecutive year, the company achieved positive Adjusted EBITDA and positive cash flow. Total net revenue rose by 26%, driven by strong sales in the U.S. and Canada due to increased customer orders and consumer demand.

The company’s gross profit margin increased to 52%, with a gross profit margin improvement of 49%. Additionally, Adjusted EBITDA saw a 68% year-over-year increase, credited to better customer mix, enhanced profit margins, and streamlined administrative functions.

Delivra Health remains committed to further growth as it continues to strengthen its market presence.

#proactiveinveestors #delivrahealthbrandsinc #tsxv #dhb #otcqb #dhbuf #DreamWater #GlobalExpansion #UAE #MiddleEastMarket #SleepAid #HealthAndWellness #PharmacyProducts #RegulatoryCompliance #DubaiWarehouse #ProductLaunch #MarketGrowth #InternationalBusiness #HealthSupplements #LabelTranslation #Pharmaceuticals #ConsumerProducts #GlobalStrategy #HealthBrands #ExpansionNews #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Dr. Seth Lederman, CEO of Tonix Pharmaceuticals, recently shared key findings with Steve Darling from Proactive following the company's presentations at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems in Rome. The presentations detailed the eutectic formation of cyclobenzaprine HCl and mannitol, highlighting its stability and rapid dissolution, allowing for efficient transmucosal delivery of cyclobenzaprine into the bloodstream. This innovative formulation protects the drug from interacting with the basifying agent needed for absorption, offering a more effective delivery system.

Dr. Lederman emphasized the ongoing unmet need for fibromyalgia treatments, with many patients unsatisfied with current options. Tonix's lead candidate, TNX-102 SL, has shown significant potential as a once-daily bedtime treatment that could provide broad-spectrum symptom relief for fibromyalgia patients. With promising results from two Phase 3 studies, TNX-102 SL is positioned to become the first new treatment for fibromyalgia in 15 years, offering hope to millions of patients seeking better management of their symptoms.

#proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp

#Fibromyalgia #TNX102SL #FDAApproval #DrugDevelopment #PharmaceuticalInnovation #BiotechNews #ClinicalTrials

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

S&U PLC chairman Anthony Coombs the company's interim results to 31 July 2024 and the outlook moving forward. Coombs acknowledged the challenges faced by the Advantage motor finance division, largely due to regulatory changes and higher provisions. However, he emphasised that these issues are temporary and expects improvement next year.

"We are working very closely with the FCA to emerge stronger, more compliant, and more efficient," Coombs said, highlighting ongoing efforts to adapt to the new consumer duty regime. He also mentioned the positive performance of the Aspen Bridging business, which saw a 43% increase in its loan book and a 42% rise in profit before tax, reflecting strong growth among property developers and investors.

Looking ahead, Coombs remains optimistic about S&U's overall business trajectory, citing the strength of Aspen and expectations for future regulatory clarity in the Advantage business.

For more interviews like this, visit Proactive’s YouTube channel, and don’t forget to give the video a like, subscribe, and enable notifications for future updates.

#S&UPLC #MotorFinance #AspenBridging #AnthonyCoombs #ProactiveInvestors #FinancialResults #DividendUpdate #FCARegulations #PropertyInvestment #BusinessGrowth

#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Yandal Resources Ltd (ASX:YRL) managing director Chris Oorschot joins Proactive’s Tylah Tully to discuss confirmation of the presence of multiple high-grade mineralised structures at the Quarter Moon Prospect, part of the Ironstone Well-Barwidgee Gold Project in Western Australia.

Results from the first three diamond drill holes reveal up to nine parallel, narrow high-grade structures extending along 800 metres of strike, with mineralisation open along strike and at depth.

Significant intercepts include 2.8 metres at 5.9 g/t gold from 105 metres, 2.9 metres at 2.1 g/t from 144 metres and 1 metre at 6.4 g/t from 169 metres. These findings build on reverse circulation (RC) results from July, such as 6 metres at 4.2 g/t gold from 90 metres. The high-grade gold is hosted in narrow shear zones within a dolerite unit, which is a key host rock for mineralisation in the Yandal Greenstone Belt.

Oorschot called the confirmation of high-grade structures at depth a “great outcome” and emphasised that the new data would guide more confident targeting for future drilling.

Yandal’s exploration activities for the remainder of 2024 include aircore drilling at Caladan and Irulan, with several results expected in the coming months.

#ProactiveInvestors #YandalResources #ASX #GoldExploration, #QuarterMoon, #DiamondDrilling, #HighGradeGold, #Mineralisation, #WesternAustralia, #IronstoneWell, #GoldProject, #MiningUpdates, #ExplorationSuccess, #GoldMineralisation, #DoleriteHost, #RCDrilling, #StrikeLength, #ShearZones, #JundeeMiningCentre, #ChrisOorschot, #Geology, #GoldMining

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews